Buscar
01/06/2024
Diagnostic Value of Krebs von den Lungen (KL-6) for Interstitial Lung Disease: A European Prospective Cohort
Millan-Billi, P, Castellví, I, Martinez-Martinez, L, Mariscal, A, Barril, S, D'Alessandro, M, Franquet, T, Castillo, D. Diagnostic Value of Krebs von den Lungen (KL-6) for Interstitial Lung Disease: A European Prospective Cohort. ARCHIVOS DE BRONCONEUMOLOGIA. 2024; 60(6)DOI:10.1016/j.arbres.2024.03.028. PMID:38644152. IF:9.200(Q1/1D).
01/06/2024
The impact of smoking on bronchiectasis and its comorbidities
de la Rosa-Carrillo, D, de Granda-Orive, JI, Cáceres, LD, Pereyra, FG, Moreno, BR, Martínez-Garcia, MA, Suárez-Cuartin, G. The impact of smoking on bronchiectasis and its comorbidities. Expert Review of Respiratory Medicine. 2024; 18(5)DOI:10.1080/17476348.2024.2369716. PMID:38888096. IF:2.700(Q2/5D).
01/06/2024
BASELINE CHARACTERISTICS OF PATIENTS WITH ASTHMA AND PRIOR ORAL SYSTEMIC CORTICOSTEROID USE INITIATING DUPILUMAB IN A REAL-WORLD REGISTRY (RAPID)
Lugogo, NL, Heffler, E, Plaza,, Hilberg, O, Xia, C, Nash, S, Pandit-Abid, N, Jacob-Nara, JA, Sacks, H, Rowe, PJ, Deniz, Y, Hardin, M, Reed, C, Soler, X. BASELINE CHARACTERISTICS OF PATIENTS WITH ASTHMA AND PRIOR ORAL SYSTEMIC CORTICOSTEROID USE INITIATING DUPILUMAB IN A REAL-WORLD REGISTRY (RAPID). VALUE IN HEALTH. 2024; 27(6)DOI:. PMID:. IF:6.000(Q1/1D).
01/06/2024
Blood immune and endothelial cell-released extracellular vesicle changes relate to COVID-19 mortality in hospitalized patients
Suades, R, Padró, T, Domingo, P, Greco, MF, Benincasa, G, Greco, S, Madè, A, Ranucci, M, Devaux, Y, Martelli, F, Badimon, L. Blood immune and endothelial cell-released extracellular vesicle changes relate to COVID-19 mortality in hospitalized patients. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).
01/06/2024
Global cooperation and early access-clinical outcomes matter
Tibau, A, Kesselheim, AS. Global cooperation and early access-clinical outcomes matter. LANCET ONCOLOGY. 2024; 25(6)DOI:10.1016/S1470-2045(24)00210-9. PMID:38754452. IF:35.900(Q1/1D).
01/06/2024
Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM)
Gately, L, Mesía, C, Sepúlveda, JM, del Barco, S, Pineda, E, Gironés, R, Fuster, J, Dumas, M, Gill, S, Navarro, LM, Herrero, A, Dowling, A, de las Peñas, R, Vaz, MA, Alonso, M, Lwin, Z, Harrup, R, Peralta, S, Long, A, Perez-Segura, P, Ahern, E, Garate, CO, Wong, M, Campbell, R, Cuff, K, Jennens, R, Gallego, O, Underhill, C, Martinez-Garcia, M, Covela, M, Cooper, A, Brown, S, Rosenthal, M, Torres, J, Collins, IM, Gibbs, P, Balana, C. Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM). JOURNAL OF NEURO-ONCOLOGY. 2024; 168(2)DOI:10.1007/s11060-024-04668-5. PMID:38630385. IF:3.100(Q2/4D).
01/06/2024
Clinical applicability of guideline-recommended molecular targets and genometargeted cancer therapies
Tibau, A, Hwang, TJ, Avorn, J, Kesselheim, AS. Clinical applicability of guideline-recommended molecular targets and genometargeted cancer therapies. JOURNAL OF CLINICAL ONCOLOGY. 2024; 42(16)DOI:. PMID:. IF:41.900(Q1/1D).
01/06/2024
Chemotherapy sensitivity in pancreatic neoplasms with PALB2 Gene mutations: First results of PALB2 pancreatic cancer study
Serda, PC, Cullell, BM, Castet, F, Gatell, AP, Fernandez, PR, Fernandez, J, Nadal, TS, Mateo, FJP, Sorolla, MA, Cajal, TRY. Chemotherapy sensitivity in pancreatic neoplasms with PALB2 Gene mutations: First results of PALB2 pancreatic cancer study. ANNALS OF ONCOLOGY. 2024; 35DOI:10.1016/annonc.2024.05.508. PMID:. IF:65.400(Q1/1D).